PARTICIPA

PARTICIPA

martes, 10 de julio de 2018

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

https://www.bmj.com/content/362/bmj.k2505

Research

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

BMJ 2018362 doi: https://doi.org/10.1136/bmj.k2505 (Published 04 July 2018)Cite this as: BMJ 2018;362:k2505
  1. Yana Vinogradova, research fellow1,
  2. Carol Coupland, professor11,
  3. Trevor Hill, research statistician1,
  4. Julia Hippisley-Cox, professor1
    Author affiliations
  1. Correspondence to: Y Vinogradova Yana.Vinogradova@nottingham.ac.uk
  • Accepted 22 May 2018

No hay comentarios:

Publicar un comentario

Danos tu opinion, enriquece el post.